Global Handheld Melanoma Scanner Market is Anticipated to Grow at a CAGR of 8.12% Over the Forecast Period (2017-2025)

According to Goldstein Research, the major driving factor is the growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases. In the United States, 76,250 men and women were diagnosed and 9,180 men and women died of melanoma of the skin in 2012. Handheld Melanoma Scanner Market outlook also includes new product developments and capital investment as the key strategies adopted by the major players for significant expansion across the globe. However, the biggest challenge is the unavailability of handheld melanoma scanner and the trained staff in some of the emerging economies coupled with the high treatment cost of melanoma skin cancer is restraining the growth of handheld melanoma scanner market. Handheld melanoma scanner dominated the APAC Melanoma Scanner Market and accounted for the market share of 63.1% in 2017 of total melanoma scanner market attributed to the hand-held device are easy to learn and use, and it rapidly provides accurate images of the melanin, blood, and collagen below the mole or lesion. Where the Melanoma Scanner Market size is set to reach USD 850 million by 2025, at a CAGR of 7.6% over the forecast period. High investment by skin cancer diagnostic & therapeutic companies and increasing number of pipeline products for cancer diagnosis under clinical trials are the key factors which are driving the growth of market of melanoma scanners.

Browse Full Report: 


Market Segmentation

On the basis of our in-depth analysis, global handheld melanoma scanner market can be segmented as follows:

By Patient Group Skin Melanoma

  • Superficial Spreading Melanoma
  • Nodular Melanoma
  • Lentigo Maligna
  • Acral Lentiginous Melanoma

By End User

  • Hospitals
  • Clinics
  • Cancer Research Organizations

By Geography

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion)}
  • The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)}

“Global Handheld Melanoma Scanner Market Outlook 2025” contains detailed overview of the global handheld melanoma scanner market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by patient group skin melanoma and by end users.

Download Exclusive Sample Report: 


Global Handheld Melanoma Scanner Market is driving on the basis of advancement in branches of healthcare mentioned below:

Cancer Biosimilars Market

Cancer Biosimilars Market grow at robust CAGR of 25.0% during 2017 and 2025. A large number of oncology biosimilars are in pipeline, and FDA has approved 4 biosimilars, 2 for cancer treatment and 2 for supportive care. Biosimilars are required to have an identical route of administration, strength, and dosage as the reference biologic. And the expiration date coming close to various cancer biologics will lead to approval of more biosimilars.

Cancer Biomarker Market

The Cancer Biomarker Market is expected to grow at considerable CAGR over the forecast period 2017-2025. The factors such as a rise in the number of patients diagnosed with cancer, growth in the number of hospitals, and cancer targeted drug discovery are propelling the growth of the market. Early detection of cancer using the biomarker can help to save many lives. In 2018 new estimated cancer cases alone in the US are 1,735,350, out of which 609,640 are anticipated to be deaths in the same year.


Further, for the in-depth analysis, Global Handheld Melanoma Scanner Market Analysis encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the study represents the global handheld melanoma scanner market past and present trends along with market projection that will help industry professionals, technology suppliers, existing players searching for growth opportunities, new market players probing for opportunities and other investors to positions their market centred strategies according to the evolving and expected trends in the future.

Key queries countered in this global handheld melanoma scanner market report

  • What is the global handheld melanoma scanner market size by 2025 and what would be the expected growth rate of the industry?
  • What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
  • What are the handheld melanoma scanner market trends?
  • What are the factors which are driving this industry?
  • What are the major barriers to handheld melanoma scanner industry growth?
  • Who are the key players in this industry space?
  • What are the industry opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?